Apr 8, 2022 | Press Release
LEXINGTON, Mass.–(BUSINESS WIRE)–Elpis Biopharmaceuticals, an IND stage biopharmaceutical company developing next generation immunotherapies to transform cancer treatment, today presented two posters at the American Association for Cancer Research (AACR)...
Jan 12, 2022 | Uncategorized
January 12, 2022 09:30 AM Eastern Standard Time Download PDF here Elpis PR_011222 LEXINGTON, Mass.–(BUSINESS WIRE)–Elpis Biopharmaceuticals, a clinical stage biopharmaceutical company developing next generation multifunctional immunotherapies to transform...
May 18, 2021 | Press Release
LEXINGTON, MA – May 18, 2021 — Elpis Biopharmaceuticals, a biopharmaceutical company developing next generation multifunctional immunotherapies to transform cancer treatment, today announced the appointment of Dennis Benjamin, Ph.D., and Rakesh Jain, Ph.D., to...
Oct 29, 2020 | Press Release
Company raises $30 Million to allocate to pre-clinical pipeline development LEXINGTON, MA – October 29, 2020 — Elpis Biopharmaceuticals today announced the closing of a $30 million Series A financing to propel solid tumor and hematological disease therapeutics...